Filorga was founded in 1978 by Michel Tordjman, a French doctor of aesthetic medicine, with a fascination for cellular biology. Michel Tordjman pioneered NCTF®, New Cellular Treatment Factor, a unique injectable solution that prevents, slows and corrects the effects of skin aging.
Laboratories Filorga SA provides medical anti-aging cosmetics for medical professions and general consumers in France and internationally.
It offers anti-aging cosmetics for wrinkles, firmness, hydration and nutrition, pigmentation, imperfections, anti-aging, post-treatment, and eye areas, as well as cleansers, serums, medi-intensive products, and night creams; and a range of professional skin care/skin perfusion products.
The company also provides medical solutions, such as hyaluronic acid injections; injectable anti-aging therapy solutions; anti-aging peeling solutions; and phototherapy solutions for stretch marks and hair loss treatments.
It distributes its products through retail outlets, pharmacies, para pharmacies, spas, and saloons.